{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreif2xcxpcfni64njptb5mx7krt2mfblyruyoucv4py2mjd3t4w5uvm",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mkd3b44qad42"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreibooatajnetoyyhba6n7ta7v5w6umau6hu2noxzjommpbxvonhwcy"
    },
    "mimeType": "image/jpeg",
    "size": 78298
  },
  "path": "/2026/04/25/drug-story-podcast-interview-transcript/?utm_campaign=rss",
  "publishedAt": "2026-04-25T11:00:00.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "First Opinion",
    "First Opinion Podcast",
    "drug development",
    "Pharmaceuticals",
    "public health"
  ],
  "textContent": "“We're basically not using our body as directed,” says \"Drug Story\" host Thomas Goetz.",
  "title": "Opinion: The podcast telling the stories behind Ambien, Ozempic, EpiPens, and other game-changing drugs",
  "updatedAt": "2026-04-24T17:29:15.000Z"
}